Autoimmune Ocular Surface Disorders: From Molecular Immunopathogenesis to Regenerative and Surgical Therapeutics. [PDF]
Luboń W +3 more
europepmc +1 more source
Congenital aniridia: European COST action ANIRIDIA‐NET guidelines for diagnosis, management and care
Abstract Congenital aniridia is a rare ocular disorder affecting the majority of eye structures and can be associated with systemic manifestations. The main visible phenotypic characteristic is the partial or complete absence of the iris; however, foveal hypoplasia is a more frequent and reliable clinical sign. Other ocular comorbidities are associated
Davide Romano +26 more
wiley +1 more source
Genetic Characterization and Biofilm-Forming Capacity of Bacterial Population Isolated from Conjunctival Samples. [PDF]
Voinescu A +13 more
europepmc +1 more source
Histological changes of conjunctiva-associated lymphoid tissue caused by pneumonia in Holstein young cows. [PDF]
Kosenda K +11 more
europepmc +1 more source
Abstract Purpose To determine the long‐term blindness rate and related prognostic factors in eyes with open‐angle glaucoma after trabeculectomy using adjunctive mitomycin C (MMC). Methods The retrospective cohort study included 714 eyes from 714 patients with open angle glaucoma who underwent trabeculectomy using MMC.
Masato Matsuo +5 more
wiley +1 more source
A Comparative Study on the Impact of FIV and FeLV Infection on the Ocular Microbiota in Persian Cats: Insights From Co-Infection and Single Infections. [PDF]
Aftab G, Arab P, Faranoush P.
europepmc +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Conjunctival microvascular alterations in dry eye disease: A comparative study of Sjögren's and non-Sjögren's subtypes. [PDF]
Lee JE +7 more
europepmc +1 more source
Abstract Background Evidence for optimal location of subpalpebral lavage (SPL) systems is lacking. Objectives To compare the rate and types of complications with SPL systems located in central upper‐ compared with medial lower‐eyelid in hospitalised patients. Study Design Prospective, randomised treatment trial.
Annabelle E. Graham +2 more
wiley +1 more source
Dry Eye Disease: From Mechanisms to Management and Future Directions. [PDF]
Pniakowska Z +4 more
europepmc +1 more source

